Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT06947291 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Interventions

DRUG: Glumetinib Tablets
DRUG: Docetaxel for Injection (Albumin-bound)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.